An interesting paper integrating Nanopores with optical detection rather than current sensing.
-
-
Well, even ONT took almost 10 years to go from a research paper to a beta device, I think it is too premature to say whether this new tech will amount to anything interesting for now. -
The fine prints of this paper mentioned that this tech is already licensed to ONT. So this is not going to be a competitor of ONT.
If the current minion can be scaled to output 40Gb per box in the near future as ONT claimed, I don't see any big need for even higher throughput in the near future for this tech (or perhaps this tech is the secret behind the 40Gb output?). It is more important to improve the read accuracy to be on par with PacBio IMHO.Comment
-
It may not affect ONT, but people (specially graduate students) who put their resources developing software for current ONT platform will be disappointed once they switch to optical detection.Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment